METHODS: Analytical and observational of a prospective cohort (December 2021-November 2023) compared to a historical cohort (January 2020-November 2021).
METHODS: 9-bed Neonatal Intensive Care Unit (NICU, level III hospital.
METHODS: 288, 66 midline group and 222 control group.
METHODS: newborns from 24 to 42 weeks of gestation who required short peripheral or midline cannulation and treatment longer than 3 days.
METHODS: Follow-up during NICU stay and comparison with retrospective data from a historical cohort.
METHODS: Sociodemographics, success rate (permanence of the same vascular catheter without complications until finish the prescribed treatment), number of catheters, cannulation rate per patient, indwell time, complications.
RESULTS: The midline group showed a higher success rate (54.2% vs 5.6%, p < 0.001), a lower number of canalizations per patient (p < 0.001), a longer indwell time (p < 0.001) and a lower number of extravasations (p < 0.001).
CONCLUSIONS: The midline catheter has advantages over short peripheral catheters, being a useful alternative in terms of efficacy and safety for treatments lasting more than 3 days in the neonatal population that requires admission to the NICU.
方法:对前瞻性队列(2021年12月至2023年11月)与历史队列(2020年1月至2021年11月)进行分析和观察。
方法:9张病床的新生儿重症监护病房(NICU,三级医院。
方法:288、66中线组和222对照组。
方法:妊娠24至42周的新生儿,需要短的外周或中线插管和治疗时间超过3天。
方法:在NICU住院期间进行随访,并与来自历史队列的回顾性数据进行比较。
方法:社会人口统计学,成功率(在完成规定的治疗之前,相同血管导管的持久性无并发症),导管数量,每位患者的插管率,indwell时间,并发症。
结果:中线组成功率更高(54.2%vs5.6%,p<0.001),每位患者的管道数量较低(p<0.001),较长的充盈时间(p<0.001)和较低的外渗次数(p<0.001)。
结论:中线导管优于短外周导管,在需要进入NICU的新生儿群体中持续超过3天的治疗方面,是一种有用的替代方法。